BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24294911)

  • 1. Development of 3D dynamic flow model of human liver and its application to prediction of metabolic clearance of 7-ethoxycoumarin.
    Choi K; Pfund WP; Andersen ME; Thomas RS; Clewell HJ; LeCluyse EL
    Tissue Eng Part C Methods; 2014 Aug; 20(8):641-51. PubMed ID: 24294911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes.
    Carlile DJ; Stevens AJ; Ashforth EI; Waghela D; Houston JB
    Drug Metab Dispos; 1998 Mar; 26(3):216-21. PubMed ID: 9492383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suitability of hepatocyte culture models to study various aspects of drug metabolism.
    Nussler AK; Wang A; Neuhaus P; Fischer J; Yuan J; Liu L; Zeilinger K; Gerlach J; Arnold PJ; Albrecht W
    ALTEX; 2001; 18(2):91-101. PubMed ID: 11378681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver cell culture in bioreactors for in vitro drug studies as an alternative to animal testing].
    Zeilinger K; Auth S; Unger J; Grebe A; Mao L; Petrik M; Holland G; Appel K; Nüssler A; Neuhaus P; Gerlach J
    ALTEX; 2000; 17(1):3-10. PubMed ID: 11103107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.
    Kostadinova R; Boess F; Applegate D; Suter L; Weiser T; Singer T; Naughton B; Roth A
    Toxicol Appl Pharmacol; 2013 Apr; 268(1):1-16. PubMed ID: 23352505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of sandwich-cultured rat hepatocytes to determine the intrinsic clearance of compounds with different extraction ratios: 7-ethoxycoumarin and warfarin.
    Treijtel N; van Helvoort H; Barendregt A; Blaauboer BJ; van Eijkeren JC
    Drug Metab Dispos; 2005 Sep; 33(9):1325-32. PubMed ID: 15951450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
    Carlile DJ; Hakooz N; Houston JB
    Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro liver model using microfabricated scaffolds in a modular bioreactor.
    Vinci B; Cavallone D; Vozzi G; Mazzei D; Domenici C; Brunetto M; Ahluwalia A
    Biotechnol J; 2010 Feb; 5(2):232-41. PubMed ID: 19824019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic maturation of human fetal hepatocytes in four-compartment three-dimensional perfusion culture.
    Ring A; Gerlach J; Peters G; Pazin BJ; Minervini CF; Turner ME; Thompson RL; Triolo F; Gridelli B; Miki T
    Tissue Eng Part C Methods; 2010 Oct; 16(5):835-45. PubMed ID: 19883207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of an isolated perfused rainbow trout liver model: Clearance studies with 7-ethoxycoumarin.
    Nichols JW; Hoffman AD; Fitzsimmons PN
    Aquat Toxicol; 2009 Nov; 95(3):182-94. PubMed ID: 19837470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.
    Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M
    Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures.
    Gebhardt R; Hengstler JG; Müller D; Glöckner R; Buenning P; Laube B; Schmelzer E; Ullrich M; Utesch D; Hewitt N; Ringel M; Hilz BR; Bader A; Langsch A; Koose T; Burger HJ; Maas J; Oesch F
    Drug Metab Rev; 2003; 35(2-3):145-213. PubMed ID: 12959414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending hepatocyte functionality for drug-testing applications using high-viscosity alginate-encapsulated three-dimensional cultures in bioreactors.
    Miranda JP; Rodrigues A; Tostões RM; Leite S; Zimmerman H; Carrondo MJ; Alves PM
    Tissue Eng Part C Methods; 2010 Dec; 16(6):1223-32. PubMed ID: 20184401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor.
    Mueller D; Tascher G; Müller-Vieira U; Knobeloch D; Nuessler AK; Zeilinger K; Heinzle E; Noor F
    J Tissue Eng Regen Med; 2011 Aug; 5(8):e207-18. PubMed ID: 21442764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards an extended functional hepatocyte in vitro culture.
    Miranda JP; Leite SB; Muller-Vieira U; Rodrigues A; Carrondo MJ; Alves PM
    Tissue Eng Part C Methods; 2009 Jun; 15(2):157-67. PubMed ID: 19072051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of major in vivo drug metabolic pathways using primary human hepatocytes and HepaRG cells in suspension and a dynamic three-dimensional bioreactor system.
    Darnell M; Ulvestad M; Ellis E; Weidolf L; Andersson TB
    J Pharmacol Exp Ther; 2012 Oct; 343(1):134-44. PubMed ID: 22776955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-free culture of primary human hepatocytes in a miniaturized hollow-fibre membrane bioreactor for pharmacological in vitro studies.
    Lübberstedt M; Müller-Vieira U; Biemel KM; Darnell M; Hoffmann SA; Knöspel F; Wönne EC; Knobeloch D; Nüssler AK; Gerlach JC; Andersson TB; Zeilinger K
    J Tissue Eng Regen Med; 2015 Sep; 9(9):1017-26. PubMed ID: 23165723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies.
    Kanebratt KP; Janefeldt A; Vilén L; Vildhede A; Samuelsson K; Milton L; Björkbom A; Persson M; Leandersson C; Andersson TB; Hilgendorf C
    J Pharm Sci; 2021 Jan; 110(1):422-431. PubMed ID: 33122050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational fluid model incorporating liver metabolic activities in perfusion bioreactor.
    Hsu MN; Tan GD; Tania M; Birgersson E; Leo HL
    Biotechnol Bioeng; 2014 May; 111(5):885-95. PubMed ID: 24311109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved liver-specific functions of hepatocytes in 3D co-culture with endothelial cell sheets.
    Kim K; Ohashi K; Utoh R; Kano K; Okano T
    Biomaterials; 2012 Feb; 33(5):1406-13. PubMed ID: 22118777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.